speb/financial-data huggingface dataset:
HME.V balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 79674000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 10773000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 10773000.00
HME.V income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 15908000.00
HME.V income_statement (quarterly, 2025-03-31) — Normalized Income: 9685595.51
HME.V cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 16181000.00
HME.V cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -41000.00
HME.V income_statement (quarterly, 2025-03-31) — Operating Income: 12909000.00
HME.V income_statement (quarterly, 2025-03-31) — Operating Revenue: 27339000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 96983982.00
HME.V balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 945000.00
HME.V income_statement (quarterly, 2025-03-31) — Other Gand A: 1289000.00
HME.V income_statement (quarterly, 2025-03-31) — Other Income Expense: -986000.00
HME.V cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 60000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 116000.00
HME.V income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 85000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Other Properties: 6848000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Other Receivables: 4605000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Payables: 17078000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 17078000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 1322000.00
HME.V income_statement (quarterly, 2025-03-31) — Pretax Income: 11857000.00
HME.V cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 74000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Properties: 176971000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Receivables: 8419000.00
HME.V income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 13048000.00
HME.V income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2888000.00
HME.V cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -222000.00
HME.V cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -1301000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 15558000.00
HME.V income_statement (quarterly, 2025-03-31) — Salaries And Wages: 8000.00
HME.V income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1297000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Share Issued: 96983982.00
HME.V cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 8000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 79674000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 79674000.00
HME.V income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -242404.49
HME.V income_statement (quarterly, 2025-03-31) — Tax Provision: 2915000.00
HME.V income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.25
HME.V balance_sheet (quarterly, 2025-03-31) — Total Assets: 118065000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 79674000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Total Debt: 3573000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 79674000.00
HME.V income_statement (quarterly, 2025-03-31) — Total Expenses: 14430000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 38391000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 86935000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 19335000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 11510000.00
HME.V income_statement (quarterly, 2025-03-31) — Total Unusual Items: -986000.00
HME.V income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -986000.00
HME.V cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 813000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Working Capital: 12074000.00
HME.V income_statement (quarterly, 2025-06-30) — +Operating Expense: 1941000.00
HME.V income_statement (quarterly, 2025-06-30) — +Total Revenue: 24395000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 4235000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 413000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -99972000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 4711000.00
HME.V income_statement (quarterly, 2025-06-30) — Basic Average Shares: 96741897.00
HME.V income_statement (quarterly, 2025-06-30) — Basic EPS: 0.07
HME.V cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 21389000.00
HME.V cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1913000.00
HME.V cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -1913000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 3417000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Capital Stock: 57142000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 23150000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 23150000.00
HME.V cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -5301000.00
HME.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -7796000.00
HME.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -2289000.00
HME.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 11846000.00
HME.V cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 1597000.00
HME.V cash_flow (quarterly, 2025-06-30) — Changes In Cash: 1761000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Common Stock: 57142000.00
HME.V cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -5301000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 79163000.00
HME.V cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -2340000.00
HME.V income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 12476000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Current Assets: 32420000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 947000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 947000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 20061000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Current Provisions: 158000.00
HME.V cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 117000.00
HME.V cash_flow (quarterly, 2025-06-30) — Deferred Tax: 117000.00
HME.V cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2972000.00
HME.V income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 98337134.00
HME.V income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.07
HME.V income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 7053000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 11000.00
HME.V income_statement (quarterly, 2025-06-30) — EBIT: 9731000.00
HME.V income_statement (quarterly, 2025-06-30) — EBITDA: 12703000.00
HME.V cash_flow (quarterly, 2025-06-30) — End Cash Position: 23150000.00
HME.V cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -7796000.00
HME.V cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 9933000.00
HME.V cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -515000.00
HME.V income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -398000.00
HME.V income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1855000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Gross PPE: 186272000.00
HME.V income_statement (quarterly, 2025-06-30) — Gross Profit: 11919000.00
HME.V income_statement (quarterly, 2025-06-30) — Interest Expense: 201000.00
HME.V income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 201000.00
HME.V income_statement (quarterly, 2025-06-30) — Interest Income: 151000.00
HME.V income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 151000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Invested Capital: 79163000.00
HME.V cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -2289000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 2470000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 2470000.00
HME.V cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -224000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 5902000.00
HME.V cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -2340000.00
HME.V cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -2000.00
HME.V income_statement (quarterly, 2025-06-30) — Net Income: 7053000.00
HME.V income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 7053000.00
HME.V income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 7053000.00
HME.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 7053000.00
HME.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 7053000.00
HME.V cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 7053000.00
HME.V income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 7053000.00
HME.V income_statement (quarterly, 2025-06-30) — Net Interest Income: -50000.00
HME.V cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -224000.00
HME.V cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -224000.00
HME.V income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -50000.00
HME.V cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -376000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Net PPE: 86300000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 79163000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 10890000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 10890000.00
HME.V income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 13101000.00
HME.V income_statement (quarterly, 2025-06-30) — Normalized Income: 7347553.41
HME.V cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 11846000.00
HME.V cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -517000.00
HME.V income_statement (quarterly, 2025-06-30) — Operating Income: 9978000.00
HME.V income_statement (quarterly, 2025-06-30) — Operating Revenue: 24395000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 95897878.00
HME.V balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 430000.00
HME.V income_statement (quarterly, 2025-06-30) — Other Gand A: 1305000.00
HME.V income_statement (quarterly, 2025-06-30) — Other Income Expense: -398000.00
HME.V cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 74000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 116000.00
HME.V income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 86000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Other Payable: 422000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Other Properties: 6916000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Other Receivables: 7357000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Payables: 18526000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 18526000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 1489000.00
HME.V income_statement (quarterly, 2025-06-30) — Pretax Income: 9530000.00
HME.V cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 69000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Properties: 179356000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Receivables: 7781000.00
HME.V income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 12476000.00
HME.V income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2972000.00
HME.V cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -224000.00
HME.V cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -2340000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 17310000.00
HME.V income_statement (quarterly, 2025-06-30) — Salaries And Wages: 550000.00
HME.V income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1855000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Share Issued: 95897878.00
HME.V cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 550000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 79163000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 79163000.00
HME.V income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -103446.59
HME.V income_statement (quarterly, 2025-06-30) — Tax Provision: 2477000.00
HME.V income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.26
HME.V balance_sheet (quarterly, 2025-06-30) — Total Assets: 118836000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 79163000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Total Debt: 3417000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 79163000.00
HME.V income_statement (quarterly, 2025-06-30) — Total Expenses: 14417000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 39673000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 86416000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 19612000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 13869000.00
HME.V income_statement (quarterly, 2025-06-30) — Total Unusual Items: -398000.00
HME.V income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -398000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 350000.00
HME.V balance_sheet (quarterly, 2025-06-30) — Working Capital: 12359000.00
HME.V income_statement (quarterly, 2025-09-30) — +Operating Expense: 1783000.00
HME.V income_statement (quarterly, 2025-09-30) — +Total Revenue: 23142000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 6055000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 392000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -102835000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 4649000.00
HME.V income_statement (quarterly, 2025-09-30) — Basic Average Shares: 95664347.00
HME.V income_statement (quarterly, 2025-09-30) — Basic EPS: 0.07
HME.V cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 23150000.00
HME.V cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -4193000.00
HME.V cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -4193000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 3193000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Capital Stock: 55313000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 25898000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 25898000.00
HME.V cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -5244000.00
HME.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -7368000.00
HME.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -5149000.00
HME.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 15265000.00
HME.V cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 5462000.00
HME.V cash_flow (quarterly, 2025-09-30) — Changes In Cash: 2748000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Common Stock: 55313000.00
HME.V cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -5244000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 78959000.00
HME.V cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -1920000.00
HME.V income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 12044000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Current Assets: 33781000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 939000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 939000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 23936000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Current Provisions: 158000.00
HME.V cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 135000.00
HME.V cash_flow (quarterly, 2025-09-30) — Deferred Tax: 135000.00
HME.V cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 2863000.00
HME.V income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 97557440.00
HME.V income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.07
HME.V income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 6931000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Current: 11000.00
HME.V income_statement (quarterly, 2025-09-30) — EBIT: 9530000.00
HME.V income_statement (quarterly, 2025-09-30) — EBITDA: 12393000.00
HME.V cash_flow (quarterly, 2025-09-30) — End Cash Position: 25898000.00
HME.V cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -7368000.00
HME.V cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 11072000.00
HME.V cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -406000.00
HME.V income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 45000.00
HME.V income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1685000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Gross PPE: 191698000.00
HME.V income_statement (quarterly, 2025-09-30) — Gross Profit: 11098000.00
HME.V income_statement (quarterly, 2025-09-30) — Interest Expense: 199000.00
HME.V income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 199000.00
HME.V income_statement (quarterly, 2025-09-30) — Interest Income: 170000.00
HME.V income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 170000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Invested Capital: 78959000.00
HME.V cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -5149000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 2254000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 2254000.00
HME.V cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -224000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 5826000.00
HME.V cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -1920000.00
HME.V cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -9000.00
HME.V income_statement (quarterly, 2025-09-30) — Net Income: 6931000.00
HME.V income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 6931000.00
HME.V income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 6931000.00
HME.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 6931000.00
HME.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 6931000.00
HME.V cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 6931000.00
HME.V income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 6931000.00
HME.V income_statement (quarterly, 2025-09-30) — Net Interest Income: -29000.00
HME.V cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -224000.00
HME.V cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -224000.00
HME.V income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -29000.00
HME.V cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -956000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Net PPE: 88863000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 78959000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 11025000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 11025000.00
HME.V income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 12348000.00
HME.V income_statement (quarterly, 2025-09-30) — Normalized Income: 6897574.32
HME.V cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 15265000.00
HME.V cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -415000.00
HME.V income_statement (quarterly, 2025-09-30) — Operating Income: 9315000.00
HME.V income_statement (quarterly, 2025-09-30) — Operating Revenue: 23142000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 94930602.00
HME.V balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 24000.00
HME.V income_statement (quarterly, 2025-09-30) — Other Gand A: 1246000.00
HME.V income_statement (quarterly, 2025-09-30) — Other Income Expense: 45000.00
HME.V cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -150000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 116000.00
HME.V income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 98000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Other Payable: 625000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Other Properties: 6915000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Other Receivables: 6695000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Payables: 22815000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 22815000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 785000.00
HME.V income_statement (quarterly, 2025-09-30) — Pretax Income: 9331000.00
HME.V cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 20000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Properties: 184783000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Receivables: 7098000.00
HME.V income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 12044000.00
HME.V income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 2863000.00
HME.V cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -224000.00
HME.V cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -1920000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 18997000.00
HME.V income_statement (quarterly, 2025-09-30) — Salaries And Wages: 439000.00
HME.V income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1685000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Share Issued: 94930602.00
HME.V cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 439000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 78959000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 78959000.00
HME.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 11574.32
HME.V income_statement (quarterly, 2025-09-30) — Tax Provision: 2400000.00
HME.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.26
HME.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 122760000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 78959000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Total Debt: 3193000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 78959000.00
HME.V income_statement (quarterly, 2025-09-30) — Total Expenses: 13827000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 43801000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 88979000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 19865000.00
HME.V income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -9768000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 16135000.00
HME.V income_statement (quarterly, 2025-09-30) — Total Unusual Items: 45000.00
HME.V income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 45000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 760000.00
HME.V balance_sheet (quarterly, 2025-09-30) — Working Capital: 9845000.00
HME.V income_statement (annual, 2025-12-31) — +Operating Expense: 5969000.00
HME.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 864000.00
HME.V income_statement (annual, 2025-12-31) — +Total Revenue: 93865000.00
HME.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 18989000.00
HME.V balance_sheet (annual, 2025-12-31) — Accounts Payable: 2129000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2129000.00
HME.V balance_sheet (annual, 2025-12-31) — Accounts Receivable: 169000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 169000.00
HME.V balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -105700000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -105700000.00
HME.V balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 4611000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 4611000.00
HME.V income_statement (annual, 2025-12-31) — Basic Average Shares: 95846431.00
HME.V income_statement (annual, 2025-12-31) — Basic EPS: 0.29
HME.V cash_flow (annual, 2025-12-31) — Beginning Cash Position: 12550000.00
HME.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 25898000.00
HME.V cash_flow (annual, 2025-12-31) — Capital Expenditure: -14038000.00
HME.V cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -6812000.00
HME.V cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -14038000.00
HME.V cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -6812000.00
HME.V balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 2965000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 2965000.00
HME.V balance_sheet (annual, 2025-12-31) — Capital Stock: 54266000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 54266000.00
HME.V balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 19513000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 19513000.00
HME.V balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 19513000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 19513000.00
HME.V cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -15335000.00
HME.V cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -2362000.00
HME.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -22725000.00
HME.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -3684000.00
HME.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -18473000.00
HME.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -7571000.00
HME.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 48161000.00
HME.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 4870000.00
HME.V cash_flow (annual, 2025-12-31) — Change In Working Capital: 14306000.00
HME.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 3743000.00
HME.V cash_flow (annual, 2025-12-31) — Changes In Cash: 6963000.00
HME.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: -6385000.00
HME.V balance_sheet (annual, 2025-12-31) — Common Stock: 54266000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 54266000.00
HME.V cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -15335000.00
HME.V cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -2362000.00
HME.V balance_sheet (annual, 2025-12-31) — Common Stock Equity: 80592000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 80592000.00
HME.V cash_flow (annual, 2025-12-31) — Common Stock Payments: -6654000.00
HME.V cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -1093000.00
HME.V income_statement (annual, 2025-12-31) — Cost Of Revenue: 48482000.00
HME.V income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 10915000.00
HME.V balance_sheet (annual, 2025-12-31) — Current Assets: 27775000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 27775000.00
HME.V balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 903000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 903000.00
HME.V balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 903000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 903000.00
HME.V balance_sheet (annual, 2025-12-31) — Current Liabilities: 20288000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 20288000.00
HME.V balance_sheet (annual, 2025-12-31) — Current Provisions: 158000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Current Provisions: 158000.00
HME.V cash_flow (annual, 2025-12-31) — Deferred Income Tax: -6741000.00
HME.V cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -7001000.00
HME.V cash_flow (annual, 2025-12-31) — Deferred Tax: -6741000.00
HME.V cash_flow (quarterly, 2025-12-31) — Deferred Tax: -7001000.00
HME.V cash_flow (annual, 2025-12-31) — Depletion: 10529000.00
HME.V cash_flow (annual, 2025-12-31) — Depreciation: 1059000.00
HME.V cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 11588000.00
HME.V cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 2865000.00
HME.V cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1059000.00
HME.V income_statement (annual, 2025-12-31) — Diluted Average Shares: 97657112.00
HME.V income_statement (annual, 2025-12-31) — Diluted EPS: 0.29
HME.V income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 28006000.00
HME.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 5080000.00
HME.V balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 11000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 11000.00
HME.V income_statement (annual, 2025-12-31) — EBIT: 38657000.00
HME.V income_statement (quarterly, 2025-12-31) — EBIT: 7363000.00
HME.V income_statement (annual, 2025-12-31) — EBITDA: 50245000.00
HME.V income_statement (quarterly, 2025-12-31) — EBITDA: 10228000.00
HME.V cash_flow (annual, 2025-12-31) — End Cash Position: 19513000.00
HME.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 19513000.00
HME.V cash_flow (annual, 2025-12-31) — Financing Cash Flow: -22725000.00
HME.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -3684000.00
HME.V cash_flow (annual, 2025-12-31) — Free Cash Flow: 34123000.00
HME.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -1942000.00
HME.V income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 0.00
HME.V income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -1336000.00
HME.V income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 5000.00
HME.V income_statement (annual, 2025-12-31) — General And Administrative Expense: 6548000.00
HME.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1712000.00
HME.V balance_sheet (annual, 2025-12-31) — Gross PPE: 198932000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Gross PPE: 198932000.00
HME.V income_statement (annual, 2025-12-31) — Gross Profit: 45383000.00
HME.V income_statement (quarterly, 2025-12-31) — Gross Profit: 8074000.00
HME.V income_statement (annual, 2025-12-31) — Interest Expense: 771000.00
HME.V income_statement (quarterly, 2025-12-31) — Interest Expense: 195000.00
HME.V income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 771000.00
HME.V income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 195000.00
HME.V income_statement (annual, 2025-12-31) — Interest Income: 579000.00
HME.V income_statement (quarterly, 2025-12-31) — Interest Income: 148000.00
HME.V income_statement (annual, 2025-12-31) — Interest Income Non Operating: 579000.00
HME.V income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 148000.00
HME.V balance_sheet (annual, 2025-12-31) — Invested Capital: 80592000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: 80592000.00
HME.V cash_flow (annual, 2025-12-31) — Investing Cash Flow: -18473000.00
HME.V cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -7571000.00
HME.V balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 2062000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 2062000.00
HME.V balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2062000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2062000.00
HME.V cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -899000.00
HME.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -228000.00
HME.V balance_sheet (annual, 2025-12-31) — Long Term Provisions: 5231000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 5231000.00
HME.V cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -6654000.00
HME.V cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -1093000.00
HME.V cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -48000.00
HME.V cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 3000.00
HME.V income_statement (annual, 2025-12-31) — Net Income: 28006000.00
HME.V income_statement (quarterly, 2025-12-31) — Net Income: 5080000.00
HME.V income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 28006000.00
HME.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 5080000.00
HME.V income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 28006000.00
HME.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 5080000.00
HME.V income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 28006000.00
HME.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 5080000.00
HME.V income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 28006000.00
HME.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 5080000.00
HME.V cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 28006000.00
HME.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 5080000.00
HME.V income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 28006000.00
HME.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 5080000.00
HME.V income_statement (annual, 2025-12-31) — Net Interest Income: -192000.00
HME.V income_statement (quarterly, 2025-12-31) — Net Interest Income: -47000.00
HME.V cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -899000.00
HME.V cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -228000.00
HME.V cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -899000.00
HME.V cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -228000.00
HME.V income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -192000.00
HME.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -47000.00
HME.V cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -4435000.00
HME.V cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -759000.00
HME.V balance_sheet (annual, 2025-12-31) — Net PPE: 93232000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Net PPE: 93232000.00
HME.V cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 0.00
HME.V balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 80592000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 80592000.00
HME.V balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 12627000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 12627000.00
HME.V balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 12627000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 12627000.00
HME.V income_statement (annual, 2025-12-31) — Normalized EBITDA: 51581000.00
HME.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 10223000.00
HME.V income_statement (annual, 2025-12-31) — Normalized Income: 28993594.78
HME.V income_statement (quarterly, 2025-12-31) — Normalized Income: 5076456.47
HME.V cash_flow (annual, 2025-12-31) — Operating Cash Flow: 48161000.00
HME.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 4870000.00
HME.V cash_flow (annual, 2025-12-31) — Operating Gains Losses: -48000.00
HME.V cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 111000.00
HME.V income_statement (annual, 2025-12-31) — Operating Income: 39414000.00
HME.V income_statement (quarterly, 2025-12-31) — Operating Income: 7210000.00
HME.V income_statement (annual, 2025-12-31) — Operating Revenue: 93865000.00
HME.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 18989000.00
HME.V balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 94481702.00
HME.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 94481702.00
HME.V balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 3000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 3000.00
HME.V income_statement (annual, 2025-12-31) — Other Gand A: 5311000.00
HME.V income_statement (quarterly, 2025-12-31) — Other Gand A: 1471000.00
HME.V income_statement (annual, 2025-12-31) — Other Income Expense: -1336000.00
HME.V income_statement (quarterly, 2025-12-31) — Other Income Expense: 5000.00
HME.V cash_flow (annual, 2025-12-31) — Other Non Cash Items: -59000.00
HME.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -41000.00
HME.V balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 116000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 116000.00
HME.V income_statement (annual, 2025-12-31) — Other Operating Expenses: -579000.00
HME.V income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -848000.00
HME.V balance_sheet (annual, 2025-12-31) — Other Payable: 474000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Other Payable: 474000.00
HME.V balance_sheet (annual, 2025-12-31) — Other Properties: 7013000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Other Properties: 7013000.00
HME.V balance_sheet (annual, 2025-12-31) — Other Receivables: 6834000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Other Receivables: 6834000.00
HME.V balance_sheet (annual, 2025-12-31) — Payables: 19224000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Payables: 19224000.00
HME.V balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 19224000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 19224000.00
HME.V balance_sheet (annual, 2025-12-31) — Prepaid Assets: 1248000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 1248000.00
HME.V income_statement (annual, 2025-12-31) — Pretax Income: 37886000.00
HME.V income_statement (quarterly, 2025-12-31) — Pretax Income: 7168000.00
HME.V cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 163000.00
HME.V cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: -1000.00
HME.V balance_sheet (annual, 2025-12-31) — Properties: 191919000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Properties: 191919000.00
HME.V balance_sheet (annual, 2025-12-31) — Receivables: 7014000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Receivables: 7014000.00
HME.V income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 48482000.00
HME.V income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 10915000.00
HME.V income_statement (annual, 2025-12-31) — Reconciled Depreciation: 11588000.00
HME.V income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 2865000.00
HME.V cash_flow (annual, 2025-12-31) — Repayment Of Debt: -899000.00
HME.V cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -228000.00
HME.V cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -6654000.00
HME.V cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -1093000.00
HME.V balance_sheet (annual, 2025-12-31) — Retained Earnings: 21715000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 21715000.00
HME.V income_statement (annual, 2025-12-31) — Salaries And Wages: 1237000.00
HME.V income_statement (quarterly, 2025-12-31) — Salaries And Wages: 241000.00
HME.V cash_flow (annual, 2025-12-31) — Sale Of PPE: 0.00
HME.V income_statement (annual, 2025-12-31) — Selling General And Administration: 6548000.00
HME.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1712000.00
HME.V balance_sheet (annual, 2025-12-31) — Share Issued: 94481702.00
HME.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 94481702.00
HME.V income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
HME.V cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1237000.00
HME.V cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 241000.00
HME.V balance_sheet (annual, 2025-12-31) — Stockholders Equity: 80592000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 80592000.00
HME.V balance_sheet (annual, 2025-12-31) — Tangible Book Value: 80592000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 80592000.00
HME.V income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -348405.22
HME.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 1456.47
HME.V income_statement (annual, 2025-12-31) — Tax Provision: 9880000.00
HME.V income_statement (quarterly, 2025-12-31) — Tax Provision: 2088000.00
HME.V income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.26
HME.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.29
HME.V balance_sheet (annual, 2025-12-31) — Total Assets: 121123000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 121123000.00
HME.V balance_sheet (annual, 2025-12-31) — Total Capitalization: 80592000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 80592000.00
HME.V balance_sheet (annual, 2025-12-31) — Total Debt: 2965000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Total Debt: 2965000.00
HME.V balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 80592000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 80592000.00
HME.V income_statement (annual, 2025-12-31) — Total Expenses: 54451000.00
HME.V income_statement (quarterly, 2025-12-31) — Total Expenses: 11779000.00
HME.V balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 40531000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 40531000.00
HME.V balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 93348000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 93348000.00
HME.V balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 20243000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 20243000.00
HME.V income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 38841000.00
HME.V income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 67964000.00
HME.V balance_sheet (annual, 2025-12-31) — Total Tax Payable: 16621000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 16621000.00
HME.V income_statement (annual, 2025-12-31) — Total Unusual Items: -1336000.00
HME.V income_statement (quarterly, 2025-12-31) — Total Unusual Items: 5000.00
HME.V income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1336000.00
HME.V income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 5000.00
HME.V balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 323000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 323000.00
HME.V cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -128000.00
HME.V balance_sheet (annual, 2025-12-31) — Working Capital: 7487000.00
HME.V balance_sheet (quarterly, 2025-12-31) — Working Capital: 7487000.00
HME.V income_statement (quarterly, 2026-03-31) — +Operating Expense: 2527000.00
HME.V income_statement (quarterly, 2026-03-31) — +Total Revenue: 25403000.00
HME.V balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 5593000.00
HME.V balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 132000.00
HME.V balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -108916000.00
HME.V balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 3864000.00
HME.V income_statement (quarterly, 2026-03-31) — Basic Average Shares: 94309340.00
HME.V income_statement (quarterly, 2026-03-31) — Basic EPS: 0.08
HME.V cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 19513000.00
HME.V cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -2884000.00
HME.V cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -2884000.00
HME.V balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 2737000.00
HME.V balance_sheet (quarterly, 2026-03-31) — Capital Stock: 54049000.00
HME.V balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 8147000.00
HME.V balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 8147000.00
HME.V cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -2358000.00
HME.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -3559000.00
HME.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -2473000.00
HME.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -5334000.00
HME.V cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -17998000.00
HME.V cash_flow (quarterly, 2026-03-31) — Changes In Cash: -11366000.00
HME.V balance_sheet (quarterly, 2026-03-31) — Common Stock: 54049000.00
HME.V cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -2358000.00
HME.V balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 85136000.00
HME.V cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -973000.00
HME.V income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 11813000.00
HME.V balance_sheet (quarterly, 2026-03-31) — Current Assets: 21167000.00
HME.V balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 872000.00
HME.V balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 872000.00
HME.V balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 8304000.00
HME.V balance_sheet (quarterly, 2026-03-31) — Current Provisions: 158000.00
HME.V cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 426000.00
HME.V cash_flow (quarterly, 2026-03-31) — Deferred Tax: 426000.00
HME.V cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 3216000.00
HME.V income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 96307255.00
HME.V income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.08
HME.V income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 7866000.00
HME.V balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 16000.00
HME.V income_statement (quarterly, 2026-03-31) — EBIT: 10996000.00
HME.V income_statement (quarterly, 2026-03-31) — EBITDA: 14212000.00